vimarsana.com
Home
Live Updates
Assembly Biosciences Presents New Data Highlighting Viral He
Assembly Biosciences Presents New Data Highlighting Viral He
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
--Poster highlights potential of oral small molecule IFNAR agonist program to engage the IFNα pathway through a liver-focused approach to improve tolerability-- SOUTH SAN FRANCISCO, Calif., Nov. ...
Related Keywords
Boston ,
Massachusetts ,
United States ,
William Delaney ,
Shannon Ryan ,
Alliance Management ,
Assembly Biosciences ,
Nasdaq ,
Securities Exchange ,
Exchange Commission ,
Assembly Biosciences Inc ,
Risk Factors In Assembly Bio ,
Assembly Bio ,
Corporate Affairs ,
Sam Brown Inc ,
American Association ,
Liver Diseases ,
Arbutus Biopharma ,
Vivo Profiling ,
Mimicking Interferon ,
Off Treatment Responses Following ,
Reverse Transcriptase Inhibitor ,
Analysis From ,
Open Label Phase ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
Investor Relations ,
Markets ,